Pulse Electromagnetic Field Therapy Devices Market – Global Forecast to 2030 | By Type & Application

The global Pulse Electromagnetic Field Therapy Devices market size is expected to be worth around US$ 705.3 million by 2030, according to a new report by Vision Research Reports.

The global Pulse Electromagnetic Field Therapy Devices market size was valued at US$ 401.5 million in 2020 and is anticipated to grow at a CAGR of 8.8% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38985

Report Coverage

Report Scope Details
Market Size US$ 705.3 million by 2030
Growth Rate CAGR of 8.8% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Power, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Bedfont Scientific; Orthofix Holdings; I_Tech Medical Division; OSKA; Medithera; NiuDesai; Nuage Health; Oxford Medical Instruments Health; Bemer, LLC

Growth Factors

Increasing focus on the development of advanced products is expected to boost the market growth. Furthermore, increasing cases of sports injuries and road accidents are expected to boost the demand for these devices, thereby augmenting the market growth. For instance, according to the WHO, about 1.3 million people die every year due to road traffic crashes.

The increasing geriatric population across the globe and rising awareness regarding pulse electromagnetic field (PEMF) therapy devices are anticipated to boost the market growth. Technological advancements, such as the development of narrow, miniaturized PEMF therapy devices using advanced materials are expected to secure the market position. The integration of telemedicine is expected to expand the application scope of these devices.

By Power Analysis

Based on power, the PEMF therapy devices market is segmented into low frequency and high frequency. The low-frequency power segment accounted for the largest revenue share of more than 62% in 2020.

The high-frequency power segment is expected to grow at the fastest CAGR during the forecast period. High-frequency PEMF devices are suited for the treatment of conditions affecting soft tissues including muscles and tendons. Researchers have found that these devices improved edema up to some hours after the treatment session.

By Application Analysis

The pain relief application segment accounted for the highest revenue share of more than 44.5% in 2020. PEMF therapy devices provide an optimal magnetic field that reduces pain by enhancing the expansion and contraction of cells and also by detoxifying and regenerating damaged cells.

The bone growth segment is estimated to register a significant CAGR from 2021 to 2030. Pulsed electromagnetic fields are known to act on bone and osteoblasts, affecting its metabolism, despite the poor understanding of underlying mechanisms.

By End-use Analysis

The hospitals segment led the market in 2020 and accounted for more than 50% of the global revenue share. Hospitals are majorly the first choice of patients to visit for chronic pain and several bone disorders including osteoporosis and osteoarthritis, among others.

The home care settings segment is expected to grow at a significant CAGR from 2021 to 2030. The growth can be attributed to the rising healthcare awareness among individuals and product advancements.

By Regional Analysis

North America dominated the market and accounted for the largest revenue share of 42.2% in 2020. An increasing number of patients suffering from osteoporosis and osteoarthritis is predicted to boost the demand for PEMF therapy devices in the U.S. and Canada.

In Asia Pacific, the market is estimated to witness the fastest CAGR during the forecast period. Rising patient awareness levels related to the commercial availability of PEMF therapy devices and constantly improving healthcare infrastructure are anticipated to accelerate the market growth.

Key Players

  • Bedfont Scientific
  • Orthofix Holdings
  • I-Tech Medical Division
  • OSKA
  • Medithera
  • NiuDeSai
  • Nuage Health
  • Oxford Medical Instruments Health
  • Bemer, LLC

Market Segmentation

  • By Power
    • Low Frequency
    • High Frequency
  • By Application
    • Pain Management
    • Bone Growth
    • Others
  • By End-use
    • Hospitals
    • Home Care Settings
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • Thailand
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa
      • Saudi Arabia
      • South Africa
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38985

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Pulse Electromagnetic Field Therapy Devices Market, By Power

7.1.  Pulse Electromagnetic Field Therapy Devices Market, by Power, 2021-2030

7.1.1.    Low Frequency

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    High Frequency

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Pulse Electromagnetic Field Therapy Devices Market, By Application

8.1.  Pulse Electromagnetic Field Therapy Devices Market, by Application, 2021-2030

8.1.1.    Pain Management

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Bone Growth

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Pulse Electromagnetic Field Therapy Devices Market, By End User

9.1.  Pulse Electromagnetic Field Therapy Devices Market, by End User, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Home Care Settings

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Pulse Electromagnetic Field Therapy Devices Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Power (2017-2030)

10.1.2.  Market Revenue and Forecast, by Application (2017-2030)

10.1.3.  Market Revenue and Forecast, by End User (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Power (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Power (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Power (2017-2030)

10.2.2.  Market Revenue and Forecast, by Application (2017-2030)

10.2.3.  Market Revenue and Forecast, by End User (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Power (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Power (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Power (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Power (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Power (2017-2030)

10.3.2.  Market Revenue and Forecast, by Application (2017-2030)

10.3.3.  Market Revenue and Forecast, by End User (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Power (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Power (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Power (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Power (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Power (2017-2030)

10.4.2.  Market Revenue and Forecast, by Application (2017-2030)

10.4.3.  Market Revenue and Forecast, by End User (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Power (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Power (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Power (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Power (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Power (2017-2030)

10.5.2.  Market Revenue and Forecast, by Application (2017-2030)

10.5.3.  Market Revenue and Forecast, by End User (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Power (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Power (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 11.  Company Profiles

11.1.              Bedfont Scientific

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Orthofix Holdings

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              I-Tech Medical Division

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              OSKA

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Medithera

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              NiuDeSai

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Nuage Health

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Oxford Medical Instruments Health

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Bemer, LLC

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38985

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com